{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:28:04Z","timestamp":1790681284982,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.exppara.2014.12.007","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T19:42:59Z","timestamp":1418154179000},"page":"54-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Triclosan and triclosan-loaded liposomal nanoparticles in the treatment of acute experimental toxoplasmosis"],"prefix":"10.1016","volume":"149","author":[{"given":"Lobna A.","family":"El-Zawawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa","family":"El-Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen F.","family":"Mossallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba S.","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa S.","family":"Younis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.exppara.2014.12.007_bib0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1742-7843.2009.00455.x","article-title":"Human exposure to triclosan via toothpaste does not change CYP3A4 activity or plasma concentrations of thyroid hormones","volume":"105","author":"Allmyr","year":"2009","journal-title":"Basic Clin. Pharmacol. Toxicol"},{"issue":"4","key":"10.1016\/j.exppara.2014.12.007_bib0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0169-4758(86)90039-6","article-title":"Liposomes as drug carriers in leishmaniasis and malaria","volume":"2","author":"Alving","year":"1986","journal-title":"Parasitol. Today"},{"issue":"2","key":"10.1016\/j.exppara.2014.12.007_bib0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/AAC.35.2.293","article-title":"Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii","volume":"35","author":"Araujo","year":"1991","journal-title":"Antimicrob. Agents Chemother"},{"issue":"2","key":"10.1016\/j.exppara.2014.12.007_bib0025","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/AAC.36.2.326","article-title":"In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii","volume":"36","author":"Araujo","year":"1992","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.exppara.2014.12.007_bib0030","series-title":"Liposomes in Biological Systems","first-page":"1","article-title":"Development of the liposome concept","author":"Bangham","year":"1980"},{"issue":"1","key":"10.1016\/j.exppara.2014.12.007_bib0035","first-page":"17","article-title":"Some diagnostic studies on male New Zealand rabbit experimentally infected with Toxoplasma gondii strain","volume":"1","author":"Barakat","year":"2007","journal-title":"Global Vet"},{"issue":"3","key":"10.1016\/j.exppara.2014.12.007_bib0040","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4269\/ajtmh.2003.68.334","article-title":"Growth inhibitory effect of triclosan on equine and bovine Babesia parasites","volume":"68","author":"Bork","year":"2003","journal-title":"Am. J. Trop. Med. Hyg"},{"issue":"7","key":"10.1016\/j.exppara.2014.12.007_bib0045","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ijpara.2006.12.010","article-title":"Delayed parasite elimination in human infections treated with clindamycin parallels \u2018delayed death\u2019 of Plasmodium falciparum in vitro","volume":"37","author":"Burkhardt","year":"2007","journal-title":"Int. J. Parasitol"},{"key":"10.1016\/j.exppara.2014.12.007_bib0050","series-title":"Diagnostic Electron Microscopy","first-page":"141","article-title":"Thick sections: technique and applications","author":"Burns","year":"1978"},{"key":"10.1016\/j.exppara.2014.12.007_bib0055","first-page":"7","article-title":"An overview of seventy years of research (1944\u20132014) on toxoplasmosis in Colombia, South America","volume":"4","author":"Ca\u00f1\u00f3n-Franco","year":"2014","journal-title":"Parasit. Vectors"},{"issue":"6","key":"10.1016\/j.exppara.2014.12.007_bib0060","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0020-7519(00)00053-9","article-title":"Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis","volume":"30","author":"Cauchetier","year":"2000","journal-title":"Int. J. Parasitol"},{"issue":"5","key":"10.1016\/j.exppara.2014.12.007_bib0065","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1128\/AAC.34.5.775","article-title":"In vitro and in vivo effects of doxycycline on Toxoplasma gondii","volume":"34","author":"Chang","year":"1990","journal-title":"Antimicrob. Agents Chemother"},{"issue":"7","key":"10.1016\/j.exppara.2014.12.007_bib0070","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.bmcl.2013.02.019","article-title":"Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase","volume":"23","author":"Cheng","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"2","key":"10.1016\/j.exppara.2014.12.007_bib0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.etap.2007.04.008","article-title":"Short-term in vivo exposure to the water contaminant triclosan: evidence for disruption of thyroxine","volume":"24","author":"Crofton","year":"2007","journal-title":"Environ. Toxicol. Pharmacol"},{"issue":"9","key":"10.1016\/j.exppara.2014.12.007_bib0080","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics. An emerging treatment modality for cancer","volume":"7","author":"Davis","year":"2008","journal-title":"Nat. Rev. Drug Discov"},{"issue":"1","key":"10.1016\/j.exppara.2014.12.007_bib0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/jac\/dkn451","article-title":"Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle","volume":"63","author":"D'Angelo","year":"2009","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1016\/j.exppara.2014.12.007_bib0090","first-page":"185","article-title":"Triclosan: a safety profile","volume":"2","author":"DeSalva","year":"1989","journal-title":"Am. J. Dent"},{"issue":"9","key":"10.1016\/j.exppara.2014.12.007_bib0095","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/AAC.43.9.2240","article-title":"Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis","volume":"43","author":"Djurkovi\u0107-Djakovi\u0107","year":"1999","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.exppara.2014.12.007_bib0100","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1550-7408.2008.00345.x","article-title":"The history of Toxoplasma gondii \u2013 the first 100 years","volume":"55","author":"Dubey","year":"2008","journal-title":"J. Eukaryot. Microbiol"},{"issue":"1","key":"10.1016\/j.exppara.2014.12.007_bib0105","first-page":"185","article-title":"Effect of artesunate on Toxoplasma gondii: in vitro and in vivo studies","volume":"38","author":"El Zawawy","year":"2008","journal-title":"J. Egypt. Soc. Parasitol"},{"key":"10.1016\/j.exppara.2014.12.007_bib0110","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.puhe.2007.08.009","article-title":"Congenital toxoplasmosis: priorities for further health promotion action","volume":"122","author":"Elsheikha","year":"2008","journal-title":"Public Health"},{"key":"10.1016\/j.exppara.2014.12.007_bib0115","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1128\/EC.4.4.814-826.2005","article-title":"Maternal inheritance and stage-specific variation of the apicoplast in Toxoplasma gondii during development in the intermediate and definitive host","volume":"4","author":"Ferguson","year":"2005","journal-title":"Eukaryot. Cell"},{"issue":"6658","key":"10.1016\/j.exppara.2014.12.007_bib0120","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/37132","article-title":"A plastid organelle as a drug target in apicomplexan parasites","volume":"390","author":"Fichera","year":"1997","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.exppara.2014.12.007_bib0125","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1128\/AAC.40.5.1214","article-title":"Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of Ambisome","volume":"40","author":"Gangneux","year":"1996","journal-title":"Antimicrob. Agents Chemother"},{"issue":"1","key":"10.1016\/j.exppara.2014.12.007_bib0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/138945007779315579","article-title":"Fatty acid biosynthesis as a drug target in apicomplexan parasites","volume":"8","author":"Goodman","year":"2007","journal-title":"Curr. Drug Targets"},{"issue":"16","key":"10.1016\/j.exppara.2014.12.007_bib0135","doi-asserted-by":"crossref","first-page":"11110","DOI":"10.1074\/jbc.274.16.11110","article-title":"Mechanism of triclosan inhibition of bacterial fatty acid synthesis","volume":"274","author":"Heath","year":"1999","journal-title":"J. Biol. Chem"},{"issue":"1","key":"10.1016\/j.exppara.2014.12.007_bib0140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0022034511425046","article-title":"Triclosan antagonizes fluconazole activity against Candida albicans","volume":"91","author":"Higgins","year":"2012","journal-title":"J. Dent. Res"},{"key":"10.1016\/j.exppara.2014.12.007_bib0145","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.1016\/S0021-9258(18)83280-X","article-title":"Acetoacetyl-acyl carrier protein synthase. A target for the antibiotic thiolactomycin","volume":"264","author":"Jackowski","year":"1989","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.exppara.2014.12.007_bib0150","first-page":"1222","article-title":"Toxoplasma infection","volume":"vol. 1","author":"Kasper","year":"2001"},{"key":"10.1016\/j.exppara.2014.12.007_bib0155","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nbt1184-979","article-title":"Dehydration-rehydration vesicles: a simple method for high yield drug entrapment in liposomes","volume":"2","author":"Kirby","year":"1984","journal-title":"Biotechnology"},{"issue":"14","key":"10.1016\/j.exppara.2014.12.007_bib0160","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1017\/S0031182007003319","article-title":"Type I and type II fatty acid biosynthesis in Eimeria tenella: enoyl reductase activity and structure","volume":"134","author":"Lu","year":"2007","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2014.12.007_bib0165","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/clinids\/15.2.211","article-title":"Toxoplasmic encephalitis in AIDS (AIDS commentary)","volume":"15","author":"Luft","year":"1992","journal-title":"Clin. Infect. Dis"},{"key":"10.1016\/j.exppara.2014.12.007_bib0170","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/02652040400015411","article-title":"Formulation and characterization of triclosan sub-micron emulsions and nanocapsules","volume":"21","author":"Maestrelli","year":"2004","journal-title":"J. Microencapsul"},{"issue":"4","key":"10.1016\/j.exppara.2014.12.007_bib0175","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.parint.2009.08.004","article-title":"Thiolactomycin analogues as potential anti-Toxoplasma gondii agents","volume":"58","author":"Martins-Duarte","year":"2009","journal-title":"Parasitol. Int"},{"issue":"8","key":"10.1016\/j.exppara.2014.12.007_bib0180","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0966-842X(99)01547-4","article-title":"Apicomplexan plastids as drug targets","volume":"7","author":"McFadden","year":"1999","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.exppara.2014.12.007_bib0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0020-7519(01)00111-4","article-title":"Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I","volume":"31","author":"McLeod","year":"2001","journal-title":"Int. J. Parasitol"},{"issue":"1","key":"10.1016\/j.exppara.2014.12.007_bib0190","first-page":"561","article-title":"Nanoparticles \u2013 a review","volume":"5","author":"Mohanraj","year":"2006","journal-title":"Trop. J. Pharm. Res"},{"issue":"1\u20132","key":"10.1016\/j.exppara.2014.12.007_bib0195","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijpharm.2005.02.009","article-title":"Improvement of antischistosomal activity of praziquantel by incorporation into phosphatidylcholine-containing liposomes","volume":"295","author":"Mour\u00e3o","year":"2005","journal-title":"Int. J. Pharm"},{"issue":"12","key":"10.1016\/j.exppara.2014.12.007_bib0200","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1016\/j.bmcl.2013.04.035","article-title":"Development of a triclosan scaffold which allows for adaptations on both the A- and B-ring for transport peptides","volume":"23","author":"Muench","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"3","key":"10.1016\/j.exppara.2014.12.007_bib0205","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1371\/journal.pntd.0000190","article-title":"Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo","volume":"2","author":"Mui","year":"2008","journal-title":"PloS Negl. Trop. Dis"},{"issue":"2","key":"10.1016\/j.exppara.2014.12.007_bib0210","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/toxsci\/kfp271","article-title":"Short-term exposure to triclosan decreases thyroxine in vivo via upregulation of hepatic catabolism in Young Long-Evans rats","volume":"113","author":"Paul","year":"2010","journal-title":"Toxicol. Sci"},{"issue":"4","key":"10.1016\/j.exppara.2014.12.007_bib0215","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1128\/EC.3.4.855-861.2004","article-title":"Multiple triclosan targets in Trypanosoma brucei","volume":"3","author":"Paul","year":"2004","journal-title":"Eukaryot. Cell"},{"issue":"4","key":"10.1016\/j.exppara.2014.12.007_bib0220","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1590\/S0074-02761994000400017","article-title":"Schistosomal activity of alkyl aminooctane thiosulfuric acids","volume":"89","author":"Penido","year":"1994","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.exppara.2014.12.007_bib0225","series-title":"Medical Statistics Made Easy","author":"Pinkin","year":"1984"},{"issue":"6","key":"10.1016\/j.exppara.2014.12.007_bib0230","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.10","article-title":"Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic","volume":"26","author":"Puri","year":"2009","journal-title":"Crit. Rev. Ther. Drug Carrier Syst"},{"issue":"11","key":"10.1016\/j.exppara.2014.12.007_bib0235","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/AAC.37.11.2371","article-title":"In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii","volume":"37","author":"Romand","year":"1993","journal-title":"Antimicrob. Agents Chemother"},{"issue":"9","key":"10.1016\/j.exppara.2014.12.007_bib0240","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1128\/AAC.40.9.2015","article-title":"In vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondii","volume":"40","author":"Romand","year":"1996","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.exppara.2014.12.007_bib0245","first-page":"585","article-title":"Organelle targeting: third level of drug targeting","volume":"7","author":"Sakhrani","year":"2013","journal-title":"Drug. Des. Devel. Ther"},{"issue":"24","key":"10.1016\/j.exppara.2014.12.007_bib0250","doi-asserted-by":"crossref","first-page":"14281","DOI":"10.1073\/pnas.2436169100","article-title":"Delivery of antimicrobials into parasites","volume":"100","author":"Samuel","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"12","key":"10.1016\/j.exppara.2014.12.007_bib0255","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1128\/AAC.47.12.3859-3866.2003","article-title":"Triclosan as a systemic antibacterial agent in a mouse model of acute bacterial challenge","volume":"47","author":"Sharma","year":"2003","journal-title":"Antimicrob. Agents Chemother"},{"issue":"9","key":"10.1016\/j.exppara.2014.12.007_bib0260","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/iub.237","article-title":"Triclosan inhibit the growth of the late liver-stage of Plasmodium","volume":"61","author":"Singh","year":"2009","journal-title":"IUBMB Life"},{"issue":"5","key":"10.1016\/j.exppara.2014.12.007_bib0265","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1128\/AAC.49.5.1794-1801.2005","article-title":"Inhibitory effect of aureobasidin A on Toxoplasma gondii","volume":"49","author":"Sonda","year":"2005","journal-title":"Antimicrob. Agents Chemother"},{"issue":"7","key":"10.1016\/j.exppara.2014.12.007_bib0270","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/cmdc.201300050","article-title":"Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii","volume":"8","author":"Stec","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.exppara.2014.12.007_bib0275","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/84612","article-title":"Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum","volume":"7","author":"Surolia","year":"2001","journal-title":"Nat. Med"},{"issue":"3","key":"10.1016\/j.exppara.2014.12.007_bib0280","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2307\/3282665","article-title":"Protection of Toxoplasma gondii-infected mice by stearylamine-bearing liposomes","volume":"76","author":"Tachibana","year":"1990","journal-title":"J. Parasitol"},{"key":"10.1016\/j.exppara.2014.12.007_bib0285","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0014-4894(78)90157-1","article-title":"Toxoplasma gondii: penetration into differentiating friend erythroleukemia cells","volume":"46","author":"Tanabe","year":"1978","journal-title":"Exp. Parasitol"},{"issue":"1","key":"10.1016\/j.exppara.2014.12.007_bib0290","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.peptides.2011.07.027","article-title":"Parasiticidal activity of Haemaphysalis longicornis longicin P4 peptide against Toxoplasma gondii","volume":"34","author":"Tanaka","year":"2012","journal-title":"Peptides"},{"issue":"17","key":"10.1016\/j.exppara.2014.12.007_bib0295","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1021\/jm9017724","article-title":"Identification and development of novel inhibitors of Toxoplasma gondii enoyl reductase","volume":"53","author":"Tipparaju","year":"2010","journal-title":"J. Med. Chem"},{"issue":"10","key":"10.1016\/j.exppara.2014.12.007_bib0300","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1600-0854.2009.00954.x","article-title":"Membrane contact sites between apicoplast and ER in Toxoplasma gondii revealed by electron tomography","volume":"10","author":"Tomova","year":"2009","journal-title":"Traffic"},{"key":"10.1016\/j.exppara.2014.12.007_bib0305","first-page":"9","article-title":"Current trends in the production and biomedical applications of liposomes: a review","volume":"4","author":"Uhumwangho","year":"2005","journal-title":"J. Biomed. Sci"},{"issue":"3","key":"10.1016\/j.exppara.2014.12.007_bib0310","first-page":"166","article-title":"Evaluation of suitable solvents for testing the anti-proliferative activity of triclosan \u2013 a hydrophobic drug in cell culture","volume":"47","author":"Vandhana","year":"2010","journal-title":"Indian J. Biochem. Biophys"},{"issue":"3","key":"10.1016\/j.exppara.2014.12.007_bib0315","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1462-5822.2008.01270.x","article-title":"Type II fatty acid synthesis is essential only for malaria parasite late liver stage development","volume":"11","author":"Vaughan","year":"2009","journal-title":"Cell. Microbiol"},{"issue":"21","key":"10.1016\/j.exppara.2014.12.007_bib0320","doi-asserted-by":"crossref","first-page":"12352","DOI":"10.1073\/pnas.95.21.12352","article-title":"Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum","volume":"95","author":"Waller","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.exppara.2014.12.007_bib0325","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/AAC.47.1.297-301.2003","article-title":"A type II pathway for fatty acid biosynthesis presents drug targets in Plasmodium falciparum","volume":"47","author":"Waller","year":"2003","journal-title":"Antimicrob. Agents Chemother"},{"issue":"8","key":"10.1016\/j.exppara.2014.12.007_bib0330","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijpara.2009.02.004","article-title":"Toxoplasmosis: a history of clinical observations","volume":"39","author":"Weissa","year":"2009","journal-title":"Int. J. Parasitol"},{"issue":"4","key":"10.1016\/j.exppara.2014.12.007_bib0335","first-page":"325","article-title":"In vivo effect of dihydroartemisinin and azithromycin on the ultrastructure of Toxoplasma gondii tachyzoites","volume":"27","author":"Yin","year":"2009","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi"},{"key":"10.1016\/j.exppara.2014.12.007_bib9010","article-title":"Lipid-Based Drug Carriers for Prodrugs to Enhance Drug Delivery","author":"Zaro","year":"2014","journal-title":"AAPS. J."},{"issue":"1","key":"10.1016\/j.exppara.2014.12.007_bib0340","first-page":"73","article-title":"The ultrastructural effects of sulfachloropyrazine on Toxoplasma gondii tachyzoites","volume":"8","author":"Zeng","year":"2013","journal-title":"Iran. J. Parasitol"},{"issue":"1","key":"10.1016\/j.exppara.2014.12.007_bib0345","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/toxsci\/kfn225","article-title":"The effects of triclosan on puberty and thyroid hormones in male Wistar rats","volume":"107","author":"Zorrilla","year":"2009","journal-title":"Toxicol. Sci"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448941400277X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448941400277X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T03:46:33Z","timestamp":1650771993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448941400277X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":69,"alternative-id":["S001448941400277X"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2014.12.007","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triclosan and triclosan-loaded liposomal nanoparticles in the treatment of acute experimental toxoplasmosis","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2014.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}